SaMD Readiness in Australia
Before Developing Digital Health Solutions
Learn how to prepare your organisation for Software as a Medical Device (SaMD) regulation in Australia. Key TGA requirements, ISO standards, and compliance steps.
As Australia accelerates its adoption of digital health technologies, Software as a Medical Device (SaMD) has become a critical area for healthcare organisations, med-tech companies, and digital health developers. Whether building an AI-driven diagnostic tool or a mobile health platform, understanding SaMD readiness is essential for TGA compliance, product safety, and commercial success.
What Counts as SaMD in Australia?
The Therapeutic Goods Administration (TGA) defines SaMD as software intended for diagnosis, prevention, monitoring, prediction, prognosis, or treatment of a health condition (TGA, 2021).
Examples include:
– Clinical decision support tools
– Remote patient monitoring platforms
– AI-based risk prediction models
– Behaviour-change algorithms making clinical claims
Understanding whether your product is SaMD—or exempt—is the first step in determining your regulatory pathway.
Key Regulatory Requirements for SaMD Readiness
1. Quality Management System (QMS)
Organisations must implement an ISO 13485:2016-aligned QMS to manage safety, documentation, and traceability. This includes:
– Risk management (ISO 14971:2019)
– Software lifecycle processes (IEC 62304:2006)
– Usability engineering (IEC 62366-1:2015)
– Post-market monitoring procedures
2. Clinical Evidence and Safety Data
The TGA requires clear evidence that the software is safe, effective, and clinically appropriate. Evidence may include usability studies, real-world performance data, validation studies, or literature-based evaluations (FDA, 2022).
3. Cybersecurity and Interoperability
Modern SaMD must address cybersecurity across the product lifecycle. This involves encryption, penetration testing, vulnerability risk management, and compliance with the Australian Privacy Principles (APPs).
Interoperability using HL7® FHIR®, safe APIs, and secure integrations is increasingly expected across Australian digital health systems.
Practical Steps to Achieve SaMD Readiness
• Start regulatory planning early (before design and development).
• Document clinical claims clearly to avoid regulatory ambiguity.
• Conduct human-factors and usability studies.
• Prepare a robust technical file aligned with TGA expectations.
• Implement continuous monitoring once deployed.
Why SaMD Readiness Matters
Organisations that embed SaMD practices early reduce regulatory delays, build trust with clinical partners, and accelerate time-to-market. In Australia’s evolving digital health ecosystem, compliance is not just regulatory; it’s a competitive advantage.
References
1. Therapeutic Goods Administration. “Regulation of Software-Based Medical Devices.” TGA, 2021–2023.
2. ISO 13485:2016 Medical Devices—Quality Management Systems.
3. ISO 14971:2019 Medical Devices—Application of Risk Management.
4. IEC 62304:2006 Medical Device Software—Software Lifecycle Processes.
5. U.S. Food & Drug Administration. “Software as a Medical Device (SaMD): Clinical Evaluation.” FDA, 2022.
